MetaCap

Tyra Biosciences Earnings

NASDAQ: TYRAHealth CareBiotechnology: Pharmaceutical PreparationsUSD

19.94-0.03 (-0.15%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Next earnings date

Wed, Nov 4, 2026

Fiscal period

Sep/2026

EPS estimate

$-0.66

Tyra Biosciences earnings summary

Tyra Biosciences is scheduled to report Sep/2026 earnings on Nov 4, 2026, with analysts expecting EPS of $-0.66. In its most recent report on Aug 4, 2026 (Q2 2026), TYRA posted EPS of $-0.69. Across the last 16 reports, TYRA shares moved an average of 7.1% (in either direction) in the first trading session after results, rising 7 times and falling 9 times.

Summary generated from market data by MetaCap's automated system. Methodology

TYRA earnings history

Tyra Biosciences reported EPS versus estimates
Report dateEPS est.EPS actualSurprisePrice reaction
Aug 4, 2026—$-0.69—-4.6%
May 13, 2026—$-0.64—-12.3%
Mar 2, 2026—$-0.57—+3.4%
Nov 5, 2025—$-0.50—+9.8%
Aug 14, 2025—$-0.47—+9.1%
May 8, 2025—$-0.47—-1.0%
Mar 27, 2025—$-0.43—-20.8%
Nov 7, 2024—$-0.41—-4.5%
Aug 7, 2024—$-0.32—+8.3%
May 9, 2024—$-0.35—+5.2%
Mar 19, 2024—$-0.54—-1.9%
Nov 7, 2023—$-0.49—-3.0%
Aug 10, 2023—$-0.31—-5.3%
May 4, 2023—$-0.28—-0.2%
Mar 22, 2023—$-0.30—+0.8%
Nov 3, 2022—$-0.30—+24.2%

Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.

Related